Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Forecasted Growth Rate and Market Size of the Peptide Therapeutics Market?
The market size of peptide therapeutics has experienced steadfast expansion in the past few years. The market, which is set to ascend from $45.15 billion in 2024 to $49.21 billion in 2025, is likely to achieve a compound annual growth rate (CAGR) of 9.0%. Key factors contributing to growth during the historic period include a rise in chronic diseases, enhanced comprehension of molecular biology, and an expansion of applications within the field of oncology.
Anticipations for the peptide therapeutics market size suggest a brisk expansion in the imminent years, with projections to reach “$74.98 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.1%. The upsurge during the forecast period is driven by factors such as the growing demand for tailor-made medicine, escalating application in immunotherapy, progress in peptide delivery systems, the emergence of peptide targets in contagious diseases, and a heightened focus on uncommon diseases. The forecast period is also likely to witness key trends including advancements in peptide synthesis technology, increased investment and funding, a focus on the safety of peptide drugs, market growth in budding economies, and the incorporation of artificial intelligence (AI).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Which Factor Is Shaping The Future Of The Peptide Therapeutics Market?
The rise in chronic diseases is projected to boost the peptide therapeutics market’s growth. Chronic diseases, often incurable or long-lasting, are sometimes manageable and treated. Factors such as the growing consumption of tobacco products, poor diet, lack of exercise, and excessive alcohol use are contributing to the rise of chronic diseases. Peptide therapeutics plays a significant role in preventing and treating some of these chronic diseases. For example, the National Library of Medicine, a US-based agency, anticipates that by January 2023, the number of US individuals aged 50 and up with at least one chronic illness will surge by 99.5%, reaching 142.66 million by 2050. Consequently, the rising prevalence of chronic diseases is set to fuel the peptide therapeutics market in the forecast period.
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
What Long-Term Trends Are Likely To Affect The Peptide Therapeutics Market?
Leading enterprises in the peptide therapeutics industry are aiming to get ahead with cutting-edge innovations like cell culture process. This technique involves nurturing cells outside their native environment in controlled settings, initially extracting the cells of interest from living tissue and then preserving them for future use. To illustrate, Evonik Industries AG, a German speciality chemical company, rolled out cQrex KC in June 2023. This next-gen peptide for biopharma applications was specifically designed for the cell culture process used in generating biological drugs. This technology not only perfects the cystine supply but also increases cell culture productivity. Furthermore, cQrex KC aids in the creation of vaccines, viral vectors and cell therapies.
Which Companies Hold The Largest Market Share In The Peptide Therapeutics Sector?
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
How Does Regional Performance Compare Across The Peptide Therapeutics Industry?
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
